ReviewDiabetes & metabolism journal2022
Association between Variability of Metabolic Risk Factors and Cardiometabolic Outcomes.
Review in Diabetes & metabolism journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Season-Aware Interpretation of Aminotransferases Should Not Become Season-Based Reassurance.Liver international : official journal of the International Association for the Study of the Liver · 2026Article
- Within-Person Seasonal Variability of Aminotransferases and Long-Term Glycemic Control in Adults With Type 2 Diabetes (JDDM 85).Liver international : official journal of the International Association for the Study of the Liver · 2026Article
- Cardiometabolic Profile Segmentation in Ecuadorian University Students: A Multivariate Analysis of Lipid, Anthropometric, and Demographic Patterns.International journal of environmental research and public health · 2026Article
- Visit‑to‑visit variability of inflammation-immunity indices and prognosis in hepatocellular carcinoma.BMC gastroenterology · 2025Article
- Review
- Mobile application-based lifestyle intervention for improving glycemic control and body composition in manufacturing company employees in South Korea.Diabetology & metabolic syndrome · 2025Article
- A Clinical Review of the Connections Between Diabetes Mellitus, Periodontal Disease, and Cardiovascular Pathologies.Biomedicines · 2025Review
- Effectiveness of continuous glucose monitoring systems on glycemic control in adults with type 1 diabetes: A systematic review and meta-analysis.Metabolism open · 2025Article
- Age-stratified Characterization of Body Composition and Biochemical Profiles in Cardiometabolic Risk Assessment.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2025Observational
- The additive effect of the estimated glucose disposal rate and a body shape index on cardiovascular disease: A cross-sectional study.PloS one · 2025Article
- Association between visit-to-visit lipid variability and risk of ischemic heart disease: a cohort study in China.Endocrine · 2024Article
- Long-term variability in physiological measures in relation to mortality and epigenetic aging: prospective studies in the USA and China.BMC medicine · 2023Article
- Association between lipid variability and the risk of mortality in cancer patients not receiving lipid-lowering agents.Frontiers in oncology · 2023Article
- Dose-response relationship between physical activity and cardiometabolic risk in obese children and adolescents: A pre-post quasi-experimental study.Frontiers in physiology · 2023Article
- Variability of Metabolic Risk Factors: Causative Factor or Epiphenomenon?Diabetes & metabolism journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite strenuous efforts to reduce cardiovascular disease (CVD) risk by improving cardiometabolic risk factors, such as glucose and cholesterol levels, and blood pressure, there is still residual risk even in patients reaching treatment targets. Recently, researchers have begun to focus on the variability of metabolic variables to remove residual risks. Several clinical trials and cohort studies have reported a relationship between the variability of metabolic parameters and CVDs. Herein, we review the literature regarding the effect of metabolic factor variability and CVD risk, and describe possible mechanisms and potential treatment perspectives for reducing cardiometabolic risk factor variability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.